Parkside Financial Bank & Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39K | Buy |
199
+21
| +12% | +$4.08K | ﹤0.01% | 1056 |
|
|
2025
Q4 | $30.9K | Buy |
178
+17
| +11% | +$3.1K | ﹤0.01% | 1151 |
|
|
2025
Q3 | $30.7K | Sell |
161
-5
| -3% | -$887 | ﹤0.01% | 1102 |
|
|
2025
Q2 | $29.8K | Buy |
166
+12
| +8% | +$2.08K | ﹤0.01% | 1085 |
|
|
2025
Q1 | $26.1K | Buy |
154
+12
| +8% | +$1.97K | ﹤0.01% | 1062 |
|
|
2024
Q4 | $21.4K | Buy |
142
+8
| +6% | +$1.24K | ﹤0.01% | 1072 |
|
|
2024
Q3 | $20.8K | Buy |
134
+1
| +0.8% | +$149 | ﹤0.01% | 1051 |
|
|
2024
Q2 | $18.2K | Buy |
133
+16
| +14% | +$2.19K | ﹤0.01% | 1042 |
|
|
2024
Q1 | $15.6K | Sell |
117
-30
| -20% | -$3.89K | ﹤0.01% | 1069 |
|
|
2023
Q4 | $20.3K | Sell |
147
-52
| -26% | -$6.84K | ﹤0.01% | 977 |
|
|
2023
Q3 | $24.3K | Sell |
199
-175
| -47% | -$23.3K | 0.01% | 842 |
|
|
2023
Q2 | $52.6K | Hold |
374
| – | – | 0.01% | 590 |
|
|
2023
Q1 | $52.9K | Buy |
374
+48
| +15% | +$6.87K | 0.01% | 574 |
|
|
2022
Q4 | $51K | Buy |
326
+85
| +35% | +$12.2K | 0.01% | 561 |
|
|
2022
Q3 | $30K | Sell |
241
-211
| -47% | -$27.8K | 0.01% | 666 |
|
|
2022
Q2 | $60K | Buy |
452
+41
| +10% | +$5.59K | 0.02% | 468 |
|
|
2022
Q1 | $56K | Buy |
411
+237
| +136% | +$33K | 0.02% | 508 |
|
|
2021
Q4 | $30K | Hold |
174
| – | – | 0.01% | 681 |
|
|
2021
Q3 | $25K | Buy |
174
+15
| +9% | +$2.19K | 0.01% | 713 |
|
|
2021
Q2 | $21K | Hold |
159
| – | – | 0.01% | 760 |
|
|
2021
Q1 | $20K | Buy |
159
+2
| +1% | +$246 | 0.01% | 763 |
|
|
2020
Q4 | $19K | Buy |
157
+3
| +2% | +$366 | 0.01% | 730 |
|
|
2020
Q3 | $18K | Buy |
154
+11
| +8% | +$1.3K | 0.01% | 669 |
|
|
2020
Q2 | $16K | Sell |
143
-20
| -12% | -$2.12K | 0.01% | 701 |
|
|
2020
Q1 | $13K | Sell |
163
-13
| -7% | -$1.35K | ﹤0.01% | 658 |
|
|
2019
Q4 | $19K | Buy |
176
+5
| +3% | +$521 | 0.01% | 660 |
|
|
2019
Q3 | $18K | Hold |
171
| – | – | 0.01% | 647 |
|
|
2019
Q2 | $17K | Buy |
171
+22
| +15% | +$2.11K | 0.01% | 678 |
|
|
2019
Q1 | $13K | Buy |
149
+85
| +133% | +$7.37K | ﹤0.01% | 718 |
|
|
2018
Q4 | $5K | Buy |
64
+31
| +94% | +$2.91K | ﹤0.01% | 893 |
|
|
2018
Q3 | $3K | Sell |
33
-23
| -41% | -$2.52K | ﹤0.01% | 983 |
|
|
2018
Q2 | $6K | Buy |
56
+27
| +93% | +$2.81K | ﹤0.01% | 830 |
|
|
2018
Q1 | $3K | Hold |
29
| – | – | ﹤0.01% | 923 |
|
|
2017
Q4 | $3K | Hold |
29
| – | – | ﹤0.01% | 916 |
|
|
2017
Q3 | $3K | Hold |
29
| – | – | ﹤0.01% | 915 |
|
|
2017
Q2 | $3K | Hold |
29
| – | – | ﹤0.01% | 928 |
|
|
2017
Q1 | $3K | Sell |
29
-700
| -96% | -$66.7K | ﹤0.01% | 907 |
|
|
2016
Q4 | $67K | Buy |
729
+16
| +2% | +$1.38K | 0.03% | 286 |
|
|
2016
Q3 | $60K | Hold |
713
| – | – | 0.03% | 322 |
|
|
2016
Q2 | $58K | Hold |
713
| – | – | 0.03% | 313 |
|
|
2016
Q1 | $51K | Hold |
713
| – | – | 0.03% | 324 |
|
|
2015
Q4 | $51K | Buy |
713
+700
| +5,385% | +$47.1K | 0.03% | 318 |
|
|
2015
Q3 | $1K | Buy |
+13
| New | +$909 | ﹤0.01% | 971 |
|
Other funds holding DGX
VCM
VPM
EIG
Parkside Financial Bank & Trust's DGX Position: Q1 2026 in Review
Parkside Financial Bank & Trust increased its Quest Diagnostics (DGX) stake by 12% in Q1 2026, buying an estimated $4.08K and bringing the position to 199 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #1056.
Parkside Financial Bank & Trust first reported a position in DGX in Q3 2015 and has held it in 43 quarters since. The position peaked at $67K in Q4 2016. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Parkside Financial Bank & Trust held 199 shares of Quest Diagnostics worth $39K as of Q1 2026.
- Parkside Financial Bank & Trust bought 21 Quest Diagnostics shares in Q1 2026, an estimated $4.08K.
- Quest Diagnostics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1056 holding.
- Parkside Financial Bank & Trust first reported a position in Quest Diagnostics in Q3 2015 and has held it in 43 quarters since.
- Parkside Financial Bank & Trust's Quest Diagnostics position peaked at $67K in Q4 2016.
- 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.